{"address1": "No. 108, Jhouzih Street", "address2": "9th Floor Neihu District", "city": "Taipei", "zip": "114", "country": "Taiwan", "phone": "886 2 8751 1888", "fax": "886 2 6602 1218", "website": "https://www.abnova.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. The company's products portfolio includes SARS-CoV/CoV-2, DNA and RNA, proteins/peptides, DNAxPab, beads/dyes, lysates/slides, antibody pairs/kits, antibody and tissue arrays, in situ hybridization products, systems and automations, GMP and analyte specific reagents, and in vitro diagnostics. It also provides MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies. In addition, the company offers integrated solutions and services, including gene synthesis and cytogenetics; peptide services, protein expression, and conjugations; antibody production; and assay development services. Abnova (Taiwan) Corporation is headquartered in Taipei, Taiwan.", "maxAge": 86400, "priceHint": 2, "previousClose": 37.05, "open": 37.15, "dayLow": 35.8, "dayHigh": 37.25, "regularMarketPreviousClose": 37.05, "regularMarketOpen": 37.15, "regularMarketDayLow": 35.8, "regularMarketDayHigh": 37.25, "dividendRate": 0.46, "dividendYield": 0.012200001, "exDividendDate": 1655337600, "payoutRatio": 0.374, "fiveYearAvgDividendYield": 1.41, "beta": 0.410995, "trailingPE": 29.10569, "forwardPE": 29.344261, "volume": 549482, "regularMarketVolume": 549482, "averageVolume": 331448, "averageVolume10days": 193509, "averageDailyVolume10Day": 193509, "bid": 35.8, "ask": 35.9, "bidSize": 0, "askSize": 0, "marketCap": 2167833088, "fiftyTwoWeekLow": 31.3, "fiftyTwoWeekHigh": 73.8, "priceToSalesTrailing12Months": 5.2648487, "fiftyDayAverage": 37.65, "twoHundredDayAverage": 37.6105, "trailingAnnualDividendRate": 0.8, "trailingAnnualDividendYield": 0.021592444, "currency": "TWD", "enterpriseValue": 1887871744, "profitMargins": 0.18177, "sharesOutstanding": 60554000, "heldPercentInsiders": 0.22374001, "heldPercentInstitutions": 0.0055199997, "impliedSharesOutstanding": 0, "bookValue": 21.336, "priceToBook": 1.6779152, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1672444800, "netIncomeToCommon": 74843000, "trailingEps": 1.23, "forwardEps": 1.22, "lastSplitFactor": "1030:1000", "lastSplitDate": 1503878400, "enterpriseToRevenue": 4.585, "enterpriseToEbitda": 23.089, "52WeekChange": -0.47412586, "SandP52WeekChange": -0.033239067, "lastDividendValue": 0.46, "lastDividendDate": 1655337600, "exchange": "TAI", "quoteType": "EQUITY", "symbol": "4133.TW", "underlyingSymbol": "4133.TW", "shortName": "ABNOVA (TAIWAN) CORPORATION", "longName": "Abnova (Taiwan) Corporation", "firstTradeDateEpochUtc": 1261962000, "timeZoneFullName": "Asia/Taipei", "timeZoneShortName": "CST", "uuid": "fcfe26ad-0a1c-3dc0-b80a-4db305b3f6a9", "messageBoardId": "finmb_45036329", "gmtOffSetMilliseconds": 28800000, "currentPrice": 35.8, "recommendationKey": "none", "totalCash": 367064992, "totalCashPerShare": 6.062, "ebitda": 81764000, "totalDebt": 11411000, "quickRatio": 7.182, "currentRatio": 12.747, "totalRevenue": 411756000, "debtToEquity": 0.883, "revenuePerShare": 6.8, "returnOnAssets": 0.030299999, "returnOnEquity": 0.05978, "grossProfits": 201429000, "freeCashflow": -3637750, "operatingCashflow": 132673000, "revenueGrowth": 0.115, "grossMargins": 0.48918998, "ebitdaMargins": 0.19857, "operatingMargins": 0.15647, "financialCurrency": "TWD", "trailingPegRatio": null}